RIGL
Rigel Pharmaceuticals Inc. (New)
stockNASDAQ
At CloseOct 21, 2026 3:59:55 PM EDT
48.90USD+1.642%(+0.79)187,581
After-hoursOct 21, 2026 4:59:30 PM EDT
48.00USD-1.840%(-0.90)
Loading…
Loading…
913.82M
Healthcare
Biotechnology
CEO
Raul Rodriguez
HQ
South San Francisco, CA, USA
103
Previous Close
$48.11
Beta
0.79
52-Week High
$52.24 2025-11-28
52-Week Low
$24.95 2026-03-19
SMA 50
$46.61
SMA 200
$36.82
Avg. Vol 10D
217,940
Avg. Vol 30D
238,352
Avg. Vol 90D
310,974
Relative Vol
0.47
18.68M
18.06M
96.68%
2,855,433
15.98%
11.14
68%/32%
29.17%
23.00%
0.2500%
150,000
287
161
Nov 3, 2026 (12d)
Jun 27, 2024 · 1-for-10 (reverse)
276.8M
321.9M
16.46
31.45
126.9
Oct 2, 2026
Sep 1, 2026
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia · 
GlobeNewswire Inc.
Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® en Colombie · GlobeNewswire Inc.
RIGL Profile
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
RIGL Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 46.82 | 2026-10-14 | +4.49% | 3.128 |
| 1M | 47.09 | 2026-09-21 | +3.89% | 0.565 |
| 3M | 39.31 | 2026-07-21 | +24.45% | 0.567 |
| 6M | 32.29 | 2026-04-21 | +51.50% | 0.329 |
| 1Y | 30.27 | 2025-10-21 | +61.61% | 0.789 |
| 2Y | 14.81 | 2024-10-21 | +230.32% | — |
| 5Y | 32.80 | 2021-10-21 | +49.15% | 1.254 |
RIGL Stock Summary
Rigel Pharmaceuticals Inc. (New) (NASDAQ:RIGL) stock price today is $48.92, and today's volume is 112,494. RIGL is up 1.684% today. The 30 day average volume is 238,352. RIGL market cap is $913.82M with 18.68M shares outstanding.